Data di Pubblicazione:
2022
Abstract:
Connexin (Cx) hemichannels (HCs) are large pore hexameric structures that allow the exchange of ions, metabolites and a variety of other molecules between the cell cytoplasm and extracellular milieu. HC inhibitors are attracting growing interest as drug candidates because deregulated fluxes through HCs have been implicated in a plethora of genetic conditions and other diseases. HC activity has been mainly investigated by electrophysiological methods and/or using HC-permeable dye uptake measurements. Here, we present an all-optical assay based on fluorometric measurements of ionized calcium (Ca) uptake with a Ca-selective genetically encoded indicator (GCaMP6s) that permits the optical tracking of cytosolic Ca concentration ([Ca ]cyt) changes with high sensitivity. We exemplify use of the assay in stable pools of HaCaT cells overexpressing human Cx26, Cx46, or the pathological mutant Cx26G45E, under control of a tetracycline (Tet) responsive element (TRE) promoter (Tet-on). We demonstrate the usefulness of the assay for the characterization of new monoclonal antibodies (mAbs) targeting the extracellular domain of the HCs. Although we developed the assay on a spinning disk confocal fluorescence microscope, the same methodology can be extended seamlessly to high-throughput high-content platforms to screen other kinds of inhibitors and/or to probe HCs expressed in primary cells and microtissues.
Tipologia CRIS:
01.01 Articolo in rivista
Keywords:
bicistronic vectors; cancer; connexins; drug discovery; genetically encoded calcium indicators; genodermatoses; lentivirus; monoclonal antibodies
Elenco autori:
Peres, Chiara; Nardin, Chiara; Mammano, Fabio; Donati, Viola; Raspa, Marcello; DI PIETRO, Chiara; Marazziti, Daniela
Link alla scheda completa:
Pubblicato in: